Healthcare / Medical Care FacilitiesSES
$0.31
-0.00 (-1.59%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $14.0M · quality 58.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
57/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$359M
P/E
N/A
•EV/EBITDA
7.5x
↓ROE
2.0%
↑Gross Margin
66.2%
↑Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.0%
FCF CAGR
-45.5%
FCF margin
1.1%
FCF / Net income
0.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $171.0M · net income $7.0M · FCF $1.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $171.0M | $171.0M | $177.5M | $177.3M | $139.7M |
| Net Income | $7.0M | $7.0M | $-8.0M | $-47.3M | $-67.7M |
| EBITDA | $24.1M | $24.1M | $9.9M | $-24.5M | $-52.5M |
| EPS | — | — | -0.02 | -0.08 | -0.11 |
| Gross Margin | 66.2% | 66.2% | 67.2% | 67.3% | 65.5% |
| Operating Margin | 5.7% | 5.7% | 4.7% | 2.7% | -8.9% |
| Net Margin | 4.1% | 4.1% | -4.5% | -26.7% | -48.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.04 | 0.04 | 0.07 | 0.10 | 0.10 |
| Current Ratio | 7.82 | 7.82 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.9M | $1.9M | $28.0M | $14.0M | $11.9M |
| Returns | |||||
| ROE | 2.0% | 2.0% | -3.1% | -17.7% | -21.8% |
| Valuation | |||||
| EV/EBITDA | 7.50 | 7.50 | -2.93 | — | — |
| P/B | 0.91 | 0.91 | 0.09 | 0.14 | 0.33 |
| Growth & Yield | |||||
| Revenue Growth | -3.6% | -3.6% | 0.1% | 26.9% | — |
| EPS Growth | — | — | 80.3% | 30.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+638.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → n/d
Residual
+638.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.